Summary
Male rats were treated orally for 7 days with perazine, chlorpromazine, imipramine or phenobarbital. Isolated liver microsomes were tested for their metabolic activities towards perazine, ethylmorphine and aniline. N-Demethylation of perazine and ethylmorphine was increased 2–3.5 fold by all pretreatments. Aromatic hydroxylation of perazine was decreased in microsomes from pretreated animals, whereas aniline hydroxylation was enhanced even more by perazine and imipramine than by phenobarbital. The yield of perazine sulfoxide was increased by phenobarbital treatment only. Perazine N-oxide formation was reduced by treatment with psychoactive drugs to 75–90% of control values and by phenobarbital to less than 50%. The microsomal cytochrome P-450 concentration was slightly elevated by perazine and substantially by chlorpromazine and imipramine treatment. The tricyclic drugs investigated are potent inducers of the drug-metabolizing enzyme system, the induction pattern differing in some respects from that seen after phenobarbital.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bickel, M. H.: Untersuchungen zur Biochemie und Pharmakologie der Thymoleptika. Fortschr. Arzneimittel-Forsch. 11, 121–225 (1968).
Breyer, U.: Urinary metabolites of 10-[3′-(4″-methyl-piperazinyl)-propyl]-phenothiazine (perazine) in psychiatric patients. I. Isolation, identification and determination of metabolites. Biochem. Pharmacol. 18, 777–788 (1969).
—: Der Stoffwechsel von Perazin in vitro. Naunyn-Schmiedebergs Arch. Pharmak. 266, 302 (1970).
—: Metabolism of the phenothiazine drug perazine by liver and lung microsomes from various species. Biochem. Pharmacol. 20, 3341–3351 (1971).
— Petruch, F.: Induction of the drug-metabolizing enzyme system by tricyclic psychoactive drugs. Naunyn-Schmiedebergs Arch. Pharmak. 270, Suppl. R 14 (1971).
Cucinell, S. A., Conney, A. H., Sansur, M., Burns, J. J.: Drug interactions in man. I. Lowering effect of phenobarbital on plasma levels of bishydroxycoumarin (Dicumarol) and diphenylhydantoin (Dilantin). Clin. Pharmacol. Ther. 6, 420–429 (1965).
Emmerson, J. L., Miya, T. S.: The metabolism and excretion of S35-chlorpromazine by the rat. J. Pharmacol. exp. Ther. 137, 148–155 (1962).
Forrest, I. S., Forrest, F. M., Serra, M. T.: An attempt to correlate urinary chlorpromazine excretion with clinical response to drug therapy. Proceedings of the 5th International Congress, CINP, Excerpta Medica Intern. Congr. Series 129, 1186 (1966).
Green, D. E., Forrest, I. S., Forrest, F. M., Serra, M. T.: Inter-patient variation in chlorpromazine metabolism. Exp. Med. Surg. 23, 278–287 (1965).
Greim, H.: Synthesesteigerung und Abbauhemmung bei der Vermehrung der mikrosomalen Cytochrome P-450 und b-5 durch Phenobarbital. Naunyn-Schmiedebergs Arch. Pharmak. 266, 261–275 (1970).
Hlavica, P., Kiese, M.: N-Oxygenation of N-alkyl- and N,N-dialkylanilines by rabbit liver microsomes. Biochem. Pharmacol. 18, 1501–1509 (1969).
Jäkel, D., Paust, H., Schrappe, O.: Orientierende Untersuchungen über die Aktivierung Fremdstoffe abbauender Enzyme durch fortgesetzte Psychopharmakotherapie. Klin. Wschr. 48, 703–704 (1970).
Kanig, K., Breyer, U.: Urinary metabolites of 10-[3′-(4″-methyl-piperazinyl)-propyl]-phenothiazine (perazine) in psychiatric patients. II. Individual metabolite patterns and their changes in the course of treatment. Psychopharmacologia (Berl.) 14, 211–220 (1969).
Kato, R., Chiesara, E., Vassanelli, P.: Further studies on the inhibition and stimulation of microsomal drug-metabolizing enzymes of rat liver by various compounds. Biochem. Pharmacol. 13, 69–83 (1964).
Machinist, J. M., Orme-Johnson, W. H., Ziegler, D. M.: Microsomal oxidases. II. Properties of a microsomal N-oxide dealkylase. Biochemistry 5, 2939–2943 (1966).
Nakazawa, K.: Studies on the demethylation, hydroxylation and N-oxidation of imipramine in rat liver. Biochem. Pharmacol. 19, 1363–1369 (1970).
Nash, T.: The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem. J. 55, 416–421 (1953).
Omura, T., Sato, R.: The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. biol. Chem. 239, 2370–2378 (1964).
Oppelt, W. W., Zange, M., Ross, W. E., Remmer, H.: Comparison of microsomal drug hydroxylation in lung and liver of various species. Res. Commun. chem. Path. Pharmacol. 1, 43–56 (1970).
Platt, D. S., Cockrill, B. L.: Biochemical changes in rat liver in response to treatment with drugs and other agents. — III. Effects of centrally acting drugs. Biochem. Pharmacol. 18, 459–473 (1969).
Ross, J. J., Jr., Young, R. L., Maass, A. R.: Demethylation of chlorpromazine-(N-methyl)-C14. Science 128, 1279–1280 (1958).
Schenkman, J. B., Remmer, H., Estabrook, R. W.: Spectral studies of drug interaction with hepatic microsomal cytochrome. Molec. Pharmacol. 3, 113–123 (1967).
Schneider, G., Schneider, G.: „Ileus” als Folge chronischer Gaben von Psychopharmaka bei der Ratte. Pharmakopsychiat. 3, 273–292 (1970).
Silvestrini, B., Catanese, B., Del Basso, P.: Researches on the increase of liver weight produced by some drugs. Biochem. Pharmacol. 15, 249–254 (1966).
Vapaatalo, H. I., Idänpään-Heikkila, J. E., Neuvonen, P. J., Paasonen, M. K.: Effects of prolonged chlorpromazine treatment on the rat intestine. Acta pharmacol. (Kbh.) 27, 262–268 (1969).
Wattenberg, L. W., Leong, J. L.: Effects of phenothiazines on protective systems against polycyclic hydrocarbons. Cancer Res. 25, 365–370 (1965).
Ziegler, D. M., Pettit, F. H.: Microsomal oxidases. I. The isolation and dialkylarylamine oxygenase activity of pork liver microsomes. Biochemistry 5, 2932–2938 (1966).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Breyer, U. Perazine, chlorpromazine and imipramine as inducers of microsomal drug metabolism. Naunyn-Schmiedeberg's Arch. Pharmacol. 272, 277–288 (1972). https://doi.org/10.1007/BF00499039
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00499039